Skip to content

Clinical Outcomes of Focused Shockwave Therapy Without Adjunct Rehabilitation Compared to Standard Physical Rehabilitation in Patients With Grade I-III Knee Osteoarthritis: A Single-Blind Randomized Study

Clinical Outcomes of Focused Shockwave Therapy Without Adjunct Rehabilitation Compared to Standard Physical Rehabilitation in Patients With Grade I-III Knee Osteoarthritis: A Single-Blind Randomized Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07567365
Enrollment
60
Registered
2026-05-05
Start date
2027-09-25
Completion date
2028-09-25
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthristis

Keywords

Knee Osteoarthritis, Focused Shockwave, Pulse Wave

Brief summary

Clinical Outcomes of Focused Shockwave Therapy Without Adjunct Rehabilitation Compared to Standard Physical Rehabilitation in Patients with Grade I-III Knee Osteoarthritis: A Single-Blind Randomized Study

Interventions

OTHERPhysical Rehab

Physical rehab through the use of body weight exercises, resistance bands, weights, movement, repetitive movement.

Applying focused shockwave therapy using a focused shockwave therapy device to the treatment area.

Sponsors

Pulse Wave USA
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient must have diagnosed OA of the unilateral or bilateral knee(s) sufficient to qualify as grade I, II, or III O.A.

Exclusion criteria

* Patients without diagnosable or gradable O.A. of the knee or knees.

Design outcomes

Primary

MeasureTime frameDescription
Change in WOMAC Pain Subscale score from baseline to the primary endpoint - likely 8 or 12 weeks after treatment begins.8 to 12 weeksThe primary outcome measure will be the between-group difference in change from baseline in WOMAC Pain Subscale score at 12 weeks.

Countries

United States

Contacts

CONTACTCameron A Hall, DC, PhD
drhall@pulse-wave.us720-518-8005
PRINCIPAL_INVESTIGATORCameron A Hall, DC, PhD

Pulse Wave USA

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026